| Itaconate controls the severity of pulmonary fibrosis PP Ogger, GJ Albers, RJ Hewitt, BJ O’Sullivan, JE Powell, E Calamita, ... Science immunology 5 (52), eabc1884, 2020 | 93 | 2020 |
| CYFRA 21-1 predicts progression in idiopathic pulmonary fibrosis: a prospective longitudinal analysis of the PROFILE cohort PL Molyneaux, WA Fahy, AJ Byrne, R Braybrooke, P Saunders, ... American journal of respiratory and critical care medicine 205 (12), 1440-1448, 2022 | 24 | 2022 |
| DNA methylome alterations are associated with airway macrophage differentiation and phenotype during lung fibrosis P McErlean, CG Bell, RJ Hewitt, Z Busharat, PP Ogger, P Ghai, GJ Albers, ... American Journal of Respiratory and Critical Care Medicine 204 (8), 954-966, 2021 | 21 | 2021 |
| IRF5 regulates airway macrophage metabolic responses GJ Albers, J Iwasaki, P McErlean, PP Ogger, P Ghai, TE Khoyratty, ... Clinical & Experimental Immunology 204 (1), 134-143, 2021 | 10 | 2021 |
| Glucocorticoid Nanoparticles Show Full Therapeutic Efficacy in a Mouse Model of Acute Lung Injury and Concomitantly Reduce Adverse Effects GJ Albers, A Amouret, K Ciupka, E Montes-Cobos, C Feldmann, ... International Journal of Molecular Sciences 24 (23), 16843, 2023 | 1 | 2023 |
| Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis JM Oldham, KW Johnson, GJ Albers, E Calamita, J Mah, P Ghai, ... ERJ open research 9 (4), 2023 | 1 | 2023 |
| Itaconate as a key regulator of respiratory disease C Michalaki, GJ Albers, AJ Byrne Clinical and Experimental Immunology 215 (2), 120-125, 2024 | | 2024 |
